CORD-19:f22ac602926d152936dd6af839da45bf8290e038 / 2482-2664 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/f22ac602926d152936dd6af839da45bf8290e038","sourcedb":"CORD-19","sourceid":"f22ac602926d152936dd6af839da45bf8290e038","text":"4 In this context, AT 2 -receptor agonists, such as compound 21, have been newly developed and are expected to function as useful agents against pathological disorders in the future.","tracks":[{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T19","span":{"begin":0,"end":182},"obj":"Sentence"}],"attributes":[{"subj":"T19","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T19","span":{"begin":0,"end":182},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T19","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"Epistemic_Statements","denotations":[{"id":"T10","span":{"begin":0,"end":182},"obj":"Epistemic_statement"}],"attributes":[{"subj":"T10","pred":"source","obj":"Epistemic_Statements"}]},{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T16","span":{"begin":19,"end":21},"obj":"Disease"}],"attributes":[{"id":"A16","pred":"mondo_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/MONDO_0008840"},{"subj":"T16","pred":"source","obj":"CORD-19-PD-MONDO"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19_Custom_license_subset","color":"#93ece3","default":true},{"id":"CORD-19-Sentences","color":"#ecc993"},{"id":"Epistemic_Statements","color":"#af93ec"},{"id":"CORD-19-PD-MONDO","color":"#93ec95"}]}]}}